• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Germ Cells Tumors

Germ Cells Tumors - 22 Studies Found

Completed : Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors
: Germ Cell Tumor
: 2017-02-28
:
  • Drug: Durvalumab anti-PD-L1 mo

Completed : Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors
: Germ Cell Tumors
: 2007-12-11
:
  • Drug: Aprepitant Subjects will

Completed : Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
: Germ Cell Tumors
: 2013-06-05
:
  • Drug: Paclitaxel
  • Drug: Ifosfamide

Completed : Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
: Testicular Germ Cell Tumor
: 2016-02-05
: Other: EORTC QLQ-CIPN20 EORTC QLQ-CIPN20 is a 20-item chemotherapy-induced peripheral neuropathy-specifi
Completed : A Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures and the Risk of Testicular Germ Cell Tumor
: Testicular Germ Cell Tumor
: 2014-04-08
: Other: Phone interview and blood test Subjects will be interviewed about environmental, domestic and occ
Completed : A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent
: Extra Cranial Non Seminomateous Malignant Germ Cell Tumour
: 2014-03-27
:
  • Drug: Velbe-Bleomycin-Cisplatin

Completed : A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors
: Non-seminomatous Germ-cell Tumors
: 2014-04-10
: Drug: Cabazitaxel On Day 1 of each cycle, patients will receive cabazitaxel at a dose of 25 mg/m²,
Completed : Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin
:
  • Ovarian Cancer
  • Testicular Germ Cell Tumor

: 1999-11-01
:
  • Biological: filgrastim
  • Drug: cisplatin

Recruiting : A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors
: Relapsed / Recurrent Germ Cell Tumors
: 2013-09-20
:
  • Drug: Erlotinib
  • Drug: Sirolimus

Recruiting : Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor
: Intracranial Non-germinomatous Germ Cell Tumor
: 2016-05-24
:
  • Drug: Carboplatin
  • Drug: Etoposide

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.